Efficacy News and Research

RSS
Additional data from ChemoCentryx' study of Traficet-EN in Crohn's disease patients

Additional data from ChemoCentryx' study of Traficet-EN in Crohn's disease patients

New data from NanoBio's nanoemulsion-based adjuvant platform to be presented

New data from NanoBio's nanoemulsion-based adjuvant platform to be presented

Potentially promising data from Phase I/II study of elotuzumab presented at ASH 2009

Potentially promising data from Phase I/II study of elotuzumab presented at ASH 2009

Amgen announces results from first Phase 1/2 study of Nplate

Amgen announces results from first Phase 1/2 study of Nplate

Selenium-based antioxidant compound reduces risk of colorectal cancer

Selenium-based antioxidant compound reduces risk of colorectal cancer

CAM314 randomized Phase 3 clinical trial results released

CAM314 randomized Phase 3 clinical trial results released

Celldex Therapeutics to present poster on its first antibody-drug conjugate product

Celldex Therapeutics to present poster on its first antibody-drug conjugate product

iRGD peptide found to enhance both cancer detection and treatment

iRGD peptide found to enhance both cancer detection and treatment

Results of preclinical studies evaluating AC220 to be presented at ASH annual meeting

Results of preclinical studies evaluating AC220 to be presented at ASH annual meeting

Biogen Idec's BG-12 achieves key milestones in clinical trials for MS and RA

Biogen Idec's BG-12 achieves key milestones in clinical trials for MS and RA

Phase 3 results for European efficacy trial Z-036 in BPH with cetrorelix pamoate reported

Phase 3 results for European efficacy trial Z-036 in BPH with cetrorelix pamoate reported

Study data of Perifosine + Bortezomib combination in multiple myeloma patients presented

Study data of Perifosine + Bortezomib combination in multiple myeloma patients presented

PharmAthene presents Protexia clinical trial results at PHEMCE conference

PharmAthene presents Protexia clinical trial results at PHEMCE conference

$225,000 funding for promising epilepsy research

$225,000 funding for promising epilepsy research

Interim data from Celator Pharmaceuticals' CPX-351 trial presented at the ASH meeting

Interim data from Celator Pharmaceuticals' CPX-351 trial presented at the ASH meeting

FDA provides a Complete Response Letter for Somaxon Pharmaceuticals' Silenor NDA

FDA provides a Complete Response Letter for Somaxon Pharmaceuticals' Silenor NDA

Æterna Zentaris reports Phase 3 results of its cetrorelix pamoate Z-036 trial for BPH

Æterna Zentaris reports Phase 3 results of its cetrorelix pamoate Z-036 trial for BPH

UCB presents data on Vimpat AED at AES meeting

UCB presents data on Vimpat AED at AES meeting

ICON, CMFT collaborate to develop translational medicine facilities on the MRI campus

ICON, CMFT collaborate to develop translational medicine facilities on the MRI campus

Micromedex 2.0, the new version of clinical information system to be released

Micromedex 2.0, the new version of clinical information system to be released

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.